Dozens of congressional lawmakers are urging the Trump administration to power Eli Lilly to reinstate mandated value breaks to hospitals that take part in a federal drug low cost program however have refused to offer the corporate with claims information.
In a letter to Division of Well being and Human Providers Secretary Robert F. Kennedy Jr., the bipartisan group of lawmakers argued that Lilly is failing to adjust to federal regulation by eliminating the value breaks. The drugmaker stopped providing reductions final month to cut back what it calls duplicate reductions paid to the hospitals.
On the time, Lilly focused 50 bigger hospital techniques amongst roughly 1,000 hospitals that had not complied with a brand new coverage that was introduced this 12 months. The corporate maintained that roughly 70% of the hospitals that take part within the low cost program, or greater than 2,300, had beforehand supplied claims information.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
View All Plans

